Clinical Trials
3 trialsNCT05883449 2025-08-20
LuminICE-203
Affimed GmbH
Phase 2 Terminated
NCT02321592 2020-11-13
GHSG-AFM13
University of Cologne
Phase 2 Completed
NCT02665650 2019-05-16
Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Affimed GmbH
Phase 1 Completed